Search clinical trials for: atrovastatin

Total 959 results

Hotel Dieu de France Hospital
Pfizer; Nouvelle Société Française d'Athérosclérose

Completed

The HDL Particle Protection Study (HDL PROTECT)

Dyslipidemia in Patients With Diabetes Mellitus

Lebanon
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Lipitor Tablets (ALWAYS)

Hypercholesterolemia

Japan
Hospital de Clinicas de Porto Alegre

Unknown

Statin for Immunomudulation in Sepsis

Sepsis

Brazil
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Makerere University
University of Oxford; Case Western Reserve University

Unknown

Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial (STAR)

HIV Infection
Organon and Co

Completed

A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

Hyperlipidemia
Obafemi Awolowo University Teaching Hospital
Open Philanthropy

Recruiting

ATORvastatin in Pulmonary TUBerculosis (ATORTUB)

Tuberculosis | Pulmonary Tuberculosis | Koch's Disease

Nigeria
Hippocration General Hospital

Completed

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Coronary Artery Disease | Atherosclerosis | Endothelial Dysfunction | Oxidative Stress | HMG-CoA Reductase Inhibitor Toxicity

Greece
Abbott

Completed

A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

Pharmacokinetics

United States
Tanta University

Completed

Statin Impact on Hepatic Decompensation

Quality of Life

Egypt
Organon and Co

Completed

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

Hypercholesterolemia
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
Pfizer

Completed

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

Hypertriglyceridemia | Hyperlipoproteinemia Type IV

United States, Canada
Seoul National University Hospital
Dong-A Pharmaceutical

Completed

The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

Cardiovascular Disease | Dyslipidemia | Hypercholesterolemia

Korea, Republic of
St. Olavs Hospital
Ullevaal University Hospital; Oslo University Hospital; University Hospital of... and other collaborators

Not yet recruiting

Prophylactic Treatment With Atorvastatin for Episodic Migraine. (EStatinMig)

Episodic Migraine
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Zhongda Hospital

Not yet recruiting

High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

Acute Ischemic Stroke | Mechanical Thrombectomy

China
xieruiqin

Completed

Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy

Atrial Fibrillation

China
National Cardiovascular Center Harapan Kita Hospital...

Completed

Effect of 80-mg Atorvastatin on Myocardial Edema

Myocardial Edema
Pfizer

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease (ILLUSTRATE)

Coronary Disease | Coronary Arteriosclerosis | Hyperlipidemia

United States, Spain, Canada, Poland, Belgium, Netherlands
Beijing Hospital

Unknown

High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting (PICAS)

Carotid Artery Stenosis

China
Kamineni Institute of Dental Sciences

Completed

Atorvastatin as an Adjunct to DFDBA in Intrabony Defects

Intrabony Periodontal Defect | Chronic Periaortitis
Creighton University

Unknown

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

Cardiothoracic Surgery | Post-operative Atrial Fibrillation

United States
Scripps Health

Withdrawn

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

Myopathic Conditions

United States
Chong Kun Dang Pharmaceutical

Completed

Dyslipidemia in Cardiovascular Disease (KoLipilou)

Dyslipidemia
Organon and Co

Completed

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

Hypercholesterolemia
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

ARREST PAD (Peripheral Arterial Disease)

Insulin Resistance | Intermittent Claudication | Arterial Occlusive Disease

United States
Pfizer

Terminated

Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. (RADIANCE 2)

Mixed Hyperlipidemia

United States, Canada, Czech Republic, Finland, France, Netherlands
Central South University

Unknown

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR (ARMYDA-IMR)

Stable Angina | Unstable Angina | Acute Non-ST-segment Elevation Myocardial Infarction

China
Penza State University

Recruiting

Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19 (CONTRAST-3)

Covid19 | STEMI | NSTEMI

Russian Federation
Pfizer

Completed

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. (RADIANCE 1)

Hyperlipidemia | Hypercholesterolemia, Familial

United States, Canada, South Africa, Czech Republic, Italy, Finland, Netherlands, France
Hormozgan University of Medical Sciences

Completed

High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)

Cardiovascular Disease

Iran, Islamic Republic of
Organon and Co

Completed

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

Hypercholesterolemia
Organon and Co

Completed

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

Hypercholesterolemia
Boca Raton Regional Hospital
Pfizer

Completed

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial) (ACTIVE)

Saphenous Vein Graft Disease

Canada, United States
Wakayama Medical University

Completed

Change in Plaque Characteristics With Atorvastatin (EASY-FIT)

Atherosclerosis | Dyslipidemia | Acute Coronary Syndrome

Japan
Pfizer

Terminated

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease (ILLUMINATE)

Coronary Disease | Diabetes Mellitus

United States, Spain, Australia, Canada, Sweden, Netherlands, United Kingdom
Pfizer

Completed

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

Hyperlipidemia

United States, Canada
Sheba Medical Center

Withdrawn

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Non Alcoholic Fatty Liver Disease

Israel
Pfizer

Terminated

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Hyperlipoproteinemia Type III

Canada, United States
Pfizer

Completed

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Hyperlipidemia

United States, Germany, Norway, Belgium, Korea, Republic of, Mexico, Sweden, United Kingdom
Pfizer

Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

Hyperlipidemia | Hypercholesterolemia, Familial

Australia, Canada, United States, France, South Africa, Sweden, Norway, Denmark, Iceland
Juan D. Maya

Recruiting

Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease (ATOCHA)

Chronic Chagas Disease

Chile
Makerere University
Vaccine and Gene Therapy Institute, Florida

Completed

Atorvastatin for HAART Suboptimal Responders

Acquired Immune Deficiency Syndrome Virus
Shanghai Jiao Tong University School of Medicine

Unknown

Atorvastatin Plus Ezetimibe on Coronary Plaque Progression (AEPP)

Coronary Artery Disease

China
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Terminated

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

HIV Infections

Spain
HK inno.N Corporation

Completed

Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects

Healthy

Korea, Republic of
NYU Langone Health

Terminated

Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus

Avascular Necrosis

United States
Organon and Co
Merck Shering-Plough JV Study

Completed

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

Hypercholesterolemia
Chong Kun Dang Pharmaceutical

Completed

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Dyslipidemias

Australia

3

Subscribe